跳至主要内容
临床试验/JPRN-UMIN000003830
JPRN-UMIN000003830已完成未知

Effect of pioglitazone and metformin in combination with insulin therapy in patients with type 2 diabetes - Effect of pioglitazone and metformin in combination with insulin therapy in patients with type 2 diabetes

Chigasaki Municipal Hospital0 个研究点目标入组 250 人开始时间: 2010年7月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
250

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients with type 1 diabetes 2) Patients receiving thiazolidiones or biguanides 3) Heart failure defined as NYHA class III or above 4) Having allergy to thiazolidiones or biguanides 5) Patients with severe liver failure or renal failure 6) History of acute coronary syndrome or cerebrovascular accident with in 3 months 7) Pregnant or breastfeeding 8) Patients with familial hypercholesterolemia 9) Other patients determined to be inappropriate by physician

研究者

相似试验

进行中(未招募)
不适用
Effects of a Pioglitazone/ Metformin Fixed Combination in Comparison to Metformin in Combination with Glimepiride on Diabetic DyslipidemiaPatients with Type 2 Diabetes mellitus (HbA1c > 6.5% and >/ = 9%) and diabetic dylipidemia inefficiently treated with Metformin monotherapy (maximal individually tolerated dose) will be eligible for this trial.MedDRA version: 8.1Level: LLTClassification code 10063624Term: Type II diabetes mellitus inadequate control
EUCTR2006-004455-37-DETakeda Pharma GmbH260
进行中(未招募)
不适用
Impact of Pioglitazone, Metformin and the combination of both on cardiovascular risk in insulin-treated patients with Type 2 diabetes – The PIOcomb Study - PIOcomb Study
EUCTR2007-006706-14-ATTakeda Pharma GmbH200
进行中(未招募)
不适用
Impact of Pioglitazone, Metformin and the combination of both on cardiovascular risk in insulin-treated patients with Type 2 diabetes – The PIOcomb Study - PIOcomb StudyDiabetes mellitus type 2MedDRA version: 9.1Level: LLTClassification code 10045242Term: Type II diabetes mellitus
EUCTR2007-006706-14-DETakeda Pharma GmbH
已完成
不适用
Differential effects of metformin and pioglithazone on hs-CRP in patients with type II DM.diabetes mellitus II.non-insulin-dependent diabetes mellitus
IRCT201109067482N1Qazvin University of Medical Sciences40
已完成
不适用
Comparative Efficacy of Pioglitazone and Metformin in Glucose Variability in Type 2 Diabetestype 2 diabetes
JPRN-UMIN000001891Jikei University School of Medicine20
Effect of pioglitazone and metformin in combination... | 临床试验